The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Autologous stem cell transplantation for patients with viral hepatitis-induced liver cirrhosis: a systematic review and meta-analysis
Abstract
Background: Recently, stem cells have been used in the treatment of viral hepatitis-induced liver cirrhosis (LC), and stem cell therapy is showing potential therapeutic effects on liver function improvement. The consensus on effects and safety of stem cell therapy has not been reached, thus it is essential for us to conduct a systematic review and meat-analysis to investigate the efficacy and safety of stem cell therapy for viral hepatitis-induced LC. Materials and methods: Medline, Embase, SinoMed and Cochrane Library databases were searched with appropriate keywords through 5 August 2018. We included eight trials involving 467 patients. The pooled weight mean difference (WMD) and 95% confidence interval (CI) were calculated using a fixed or random effects model. Quality assessment and publication bias were also performed. The selected studies were considered for meta-analysis using RevMan V5.3. Results: Compared with traditional therapy group, autologous stem cell transplantation increased the level of albumin (WMD: 2.47, 95% CI: 1.05–3.90, P < 0.001), but decreased the level of total bilirubin (WMD: −2.26, 95% CI: −3.61 to −0.90, P = 0.001), alanine aminotransferase (WMD: −9.16, 95% CI: −16.47 to −1.85, P = 0.01) and prothrombin time (WMD: −3.02, 95% CI: −4.83 to −1.22, P = 0.001). Clinical symptoms such as edema, fatigue, anorexia and abdominal distention were alleviated. Model for End-Stage Liver Disease and Child–Pugh scores were decreased after stem cell therapy. Whereas, there was no statistically significant difference between two groups regarding aspartate aminotransferase, prothrombin time activity, ascites and pleural fluid. No procedure-related complications were found. Conclusion: Autologous stem cell transplantation might have beneficial effects on patients with viral hepatitis-induced LC and is relatively safe for these patients. Further high-quality randomized controlled trials are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, allogeneic transplantation often demonstrates superiority in decompensated cirrhosis.”
From From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy (2025) · cites this paper as [76]
In the citing paper
“Cells derived from healthy donors exhibit more vigorous immunomodulatory activity and more prominent paracrine effects, enabling more effective suppression of systemic inflammation and generally yielding faster therapeutic outcomes.”
From From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy (2025) · cites this paper as [76]
In the citing paper
“Optimal source selection, however, depends critically on disease stage.”
From From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy (2025) · cites this paper as [76]
In the citing paper
“For patients with compensated cirrhosis, where endogenous cellular function is relatively preserved, autologous transplantation may be preferable.”
From From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy (2025) · cites this paper as [76]
In the citing paper
“Clinical evidence suggests that both autologous and allogeneic MSCs can improve MELD scores and reduce liver fibrosis in the management of cirrhosis.”
From From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy (2025) · cites this paper as [76]
Citations
Cites
1 retracted
(2013) · Europe PMC (PubMed Central) · Cited by 75
RetractedPreferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60121-5 · Cited by 1,740
Management of Varices and Variceal Hemorrhage in Cirrhosis
Garcia-Tsao, G., & Bosch, J. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901512 · Cited by 951
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
Curry, M. P., O’Leary, J. G., Bzowej, N., Muir, A. J., Korenblat, K. M., Fenkel, J. M., Reddy, K. R., Lawitz, E., Flamm, S. L., Schiano, T., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512614 · Cited by 804
Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic Failure
Parekkadan, B., van Poll, D., Suganuma, K., Carter, E. A., Berthiaume, F., Tilles, A. W., & Yarmush, M. L. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000941 · Cited by 510
van Poll, D., Parekkadan, B., Cho, C. H., Berthiaume, F., Nahmias, Y., Tilles, A. W., & Yarmush, M. L. (2008) · Hepatology · doi:10.1002/hep.22236 · Cited by 501
Research works printed but not linked: 1
- Ouyang, 2013, Hepatic arterial transplantation of autologous bone marrow mesenchymal stem cells in treatment of decompensated liver cirrhosis, Chin J Tissue Eng Res, 17, 6455
Cited by
Liu, Y., Dong, Y., Wu, X., Xu, X., & Niu, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02882-4 · Cited by 79
Liver cirrhosis: molecular mechanisms and therapeutic interventions
Dong, Z., Wang, Y., & Jin, W. (2024) · MedComm · doi:10.1002/mco2.721 · Cited by 35
Self-citationZhu, C., Zhang, D.-H., Zhu, C.-W., Xu, J., Guo, C., Wu, X., Cao, Q.-L., & Di, G. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02625-x · Cited by 21
Bozorgi, V., Babaahmadi, M., Salehi, M., Vafaeimanesh, J., & Hajizadeh-Saffar, E. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04535-8 · Cited by 11
“These source-dependent functional differences underscore the need for personalized treatment strategies for cirrhosis [76].”
Wang, Z., Yao, L., Hu, X., Yuan, M., Chen, P., Liu, P., Zhang, Q., Xiong, Z., Dai, K., & Jiang, Y. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102198 · Cited by 12
Metadata
- Authors
- Chen, B., Pang, L., Cao, H., Wu, D., Wang, Y., Tao, Y., Wang, M., & Chen, E.
- Affiliations
- West China Hospital of Sichuan University (CN)
- Sichuan University (CN)
- Center of Infectious Diseases, West China Hospital of Sichuan University
- Corresponding author
- Chen, Bin
- Pang, Long
- Venue
- European Journal of Gastroenterology & Hepatology
- Published
- 2019-10
- Volume
- 31
- Issue
- 10
- Pages
- 1283-1291
- ISSN
- 0954-691X (ISSN-L)
- OpenAlex
- W2949789377
- Semantic Scholar
- 8d17bb984042f968a82c6e519fa250a6abadf223
- Cited by
- 14
- References
- 39
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 3
- FWCI
- 0.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- autologous stem cell transplantation, viral hepatitis, liver cirrhosis, stem cell therapy, liver function, serum albumin, total bilirubin, alanine aminotransferase, prothrombin time, MELD score, Child-Pugh score, treatment safety
- MeSH terms
- Hepatitis, Viral, Human, Humans, Liver Cirrhosis, Transplantation, Autologous, Models, Statistical, Treatment Outcome, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autologous stem cell transplantation for patients with viral hepatitis-induced liver cirrhosis: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1097/meg.0000000000001455
- The paper
- Chen, B., Pang, L., Cao, H., Wu, D., Wang, Y., Tao, Y., Wang, M., & Chen, E. (2019). Autologous stem cell transplantation for patients with viral hepatitis-induced liver cirrhosis: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000001455
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.